tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Butcher SP et al. Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. 1997 J. Neurosci. pmid:9278529
Vaden SL Cyclosporine and tacrolimus. 1997 Semin. Vet. Med. Surg. Small Anim. pmid:9283240
Ellouk-Achard S et al. Implication of CYP 3A in the toxicity of cyclosporin G (CsG), cyclosporin A (CsA) and FK506 on rat hepatocytes in primary culture. 1997 Arch. Toxicol. pmid:9209689
Hatanaka H and Shimomura K [Immunosuppressive activity of a microbial product]. 1997 Nippon Yakurigaku Zasshi pmid:9503409
Devine SM et al. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis. 1997 Biol. Blood Marrow Transplant. pmid:9209738
Su Y et al. Cyclosporin A but not FK506 inhibits thyroid hormone-induced apoptosis in tadpole intestinal epithelium. 1997 FASEB J. pmid:9212079
Maeda T [Experimental study of the effectiveness of immunosuppression therapy using FK506 and 15-deoxyspergualin in concordant xenotransplantation]. 1997 Nihon Kyobu Geka Gakkai Zasshi pmid:9217381
duBell WH et al. Effect of the immunosupressant FK506 on excitation-contraction coupling and outward K+ currents in rat ventricular myocytes. 1997 J. Physiol. (Lond.) pmid:9218211
de-la-Serna-Higuera C et al. Tacrolimus-induced bone marrow suppression. 1997 Lancet pmid:9291912
Yoshikawa H et al. Fc gammaRIII-mediated regulation of hematopoiesis in murine bone marrow cells by interleukin-3 and CD95 (Fas/Apo-1). 1997 Blood pmid:9292524
Jain A et al. Pregnancy after liver transplantation under tacrolimus. 1997 Transplantation pmid:9293865
Fletcher L Specific neuroimmunophilin ligands to treat neurodegenerative disease. 1997 Mol Med Today pmid:9449119
Lauerma AI et al. Absorption of topical tacrolimus (FK506) in vitro through human skin: comparison with cyclosporin A. 1997 Skin Pharmacol. pmid:9449161
Alak AM Measurement of tacrolimus (FK506) and its metabolites: a review of assay development and application in therapeutic drug monitoring and pharmacokinetic studies. 1997 Ther Drug Monit pmid:9200777
Saitoh O et al. Cyclosporine A inhibits interleukin-8 production in a human colon epithelial cell line (HT-29). 1997 J. Gastroenterol. pmid:9349985
Hebebrand D et al. Nerve xenograft transplantation. Immunosuppression with FK-506 and RS-61443. 1997 J Hand Surg Br pmid:9222906
Kageyama M et al. FK506-binding proteins regulate smooth muscle contractility by altering neurotransmitter release. 1997 Eur. J. Pharmacol. pmid:9314039
Rejto PA and Verkhivker GM Mean field analysis of FKBP12 complexes with FK506 and rapamycin: implications for a role of crystallographic water molecules in molecular recognition and specificity. 1997 Proteins pmid:9223178
Reynolds KA et al. Biosynthesis of the shikimate-derived starter unit of the immunosuppressant ascomycin: stereochemistry of the 1,4-conjugate elimination. 1997 J. Antibiot. pmid:9315087
Birnbaum AH et al. Recurrence of autoimmune hepatitis in children after liver transplantation. 1997 J. Pediatr. Gastroenterol. Nutr. pmid:9226522
Alarcón CM and Heitman J FKBP12 physically and functionally interacts with aspartokinase in Saccharomyces cerevisiae. 1997 Mol. Cell. Biol. pmid:9315655
Scott JE et al. Dynamic equilibrium between calcineurin and kinase activities regulates the phosphorylation state and localization of the nuclear factor of activated T-cells. 1997 Biochem. J. pmid:9182723
Goodyear N et al. The 37 kDa immunophilin has uracil DNA glycosylase but not rotamase activity. 1997 Clin. Biochem. pmid:9316745
Suzuki N et al. In vivo mechanisms for the inhibition of T lymphocyte activation by long-term therapy with tacrolimus (FK-506): experience in patients with Behçet's disease. 1997 Arthritis Rheum. pmid:9182928
Rudi J et al. Prevalence of serum antibodies to Helicobacter pylori and to CagA protein in liver transplant recipients. 1997 Am. J. Gastroenterol. pmid:9317070
Odom A et al. Calcineurin is required for virulence of Cryptococcus neoformans. 1997 EMBO J. pmid:9184205
Kesten S et al. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome. 1997 J. Heart Lung Transplant. pmid:9322139
Nishinaka H et al. Graft persistence effectively induces and maintains donor-specific unresponsiveness. 1997 J. Surg. Res. pmid:9184673
Cardoso CM et al. Uncoupling of Ca2+ transport ATPase in muscle and blood platelets by diacylglycerol analogues and cyclosporin A antagonism. 1997 Biochem. J. pmid:9581558
Ko WJ et al. Hypomagnesia and arrhythmia corrected by replacing cyclosporine with FK506 in a heart transplant recipient. 1997 J. Heart Lung Transplant. pmid:9322151
Miwa S et al. Effect of anti-intercellular adhesion molecule-1 and anti-leukocyte function associated antigen-1 monoclonal antibodies on rat-to-mouse cardiac xenograft rejection. 1997 Surgery pmid:9186469
Arbustini E et al. Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study. 1997 J. Heart Lung Transplant. pmid:9322152
Fujino H et al. Stimulatory roles of muscarinic acetylcholine receptors on T cell antigen receptor/CD3 complex-mediated interleukin-2 production in human peripheral blood lymphocytes. 1997 Mol. Pharmacol. pmid:9187267
Denecker G et al. Differential role of calcium in tumour necrosis factor-mediated apoptosis and secretion of granulocyte-macrophage colony-stimulating factor in a T cell hybridoma. 1997 Cytokine pmid:9325011
Hausen B and Morris RE Review of immunosuppression for lung transplantation. Novel drugs, new uses for conventional immunosuppressants, and alternative strategies. 1997 Clin. Chest Med. pmid:9187827
Fujita T et al. Prolonged survival of rat skin allograft by treatment with FK506 ointment. 1997 Transplantation pmid:9326422
Göthel SF et al. An internal FK506-binding domain is the catalytic core of the prolyl isomerase activity associated with the Bacillus subtilis trigger factor. 1997 Eur. J. Biochem. pmid:9063446
Dumont FJ FK506 enhances IL-13 production by T cells activated through CD3/CD28. 1997 Int. Arch. Allergy Immunol. pmid:9363914
Motamedi H et al. Structural organization of a multifunctional polyketide synthase involved in the biosynthesis of the macrolide immunosuppressant FK506. 1997 Eur. J. Biochem. pmid:9063448
Taylor PJ et al. Improved therapeutic drug monitoring of tacrolimus (FK506) by tandem mass spectrometry. 1997 Clin. Chem. pmid:9365410
Guckelberger O et al. Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation. 1997 Clin Transplant pmid:9067697
Mueller AR et al. Association between hepatitis and rejection: upregulation of cytokines and extracellular matrix parameters. 1997 Transplant. Proc. pmid:9365585
Singh N et al. Clinical spectrum of invasive cryptococcosis in liver transplant recipients receiving tacrolimus. 1997 Clin Transplant pmid:9067698
Platz KP et al. FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation. 1997 Transplant. Proc. pmid:9365598
Victor RG et al. Mechanism of Ca(2+)-dependent inactivation of L-type Ca2+ channels in GH3 cells: direct evidence against dephosphorylation by calcineurin. 1997 J. Membr. Biol. pmid:9070464
Platz KP et al. Indications for mycofenolate mofetil therapy after liver transplantation. 1997 Transplant. Proc. pmid:9365601
Demirbas A et al. FK 506 in simultaneous pancreas/kidney transplantation: the University of Miami experience. 1997 Transplant. Proc. pmid:9365608
Ferron GM et al. Population pharmacokinetics of sirolimus in kidney transplant patients. 1997 Clin. Pharmacol. Ther. pmid:9129559
Kliem V et al. Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients. 1997 Transplant. Proc. pmid:9365627
Weil SJ et al. Chemotaxis of macrophages by a peritoneal fluid protein in women with endometriosis. 1997 Fertil. Steril. pmid:9130891
Xu M et al. Effect of peritransplant FTY720 alone or in combination with posttransplant FK 506 in a rat model of cardiac allotransplantation. 1997 Transplant. Proc. pmid:9365631
Karlsson H et al. Energy levels in resting and mitogen-stimulated human lymphocytes during treatment with FK506 or cyclosporin A in vitro. 1997 Biochim. Biophys. Acta pmid:9131051
Gavlik A et al. Mycophenolate mofetil rescue therapy in liver transplant recipients: an extended follow-up. 1997 Transplant. Proc. pmid:9365633
Pratt WB The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. 1997 Annu. Rev. Pharmacol. Toxicol. pmid:9131255
Niederstadt C et al. Effect of FK506 on magnesium homeostasis after renal transplantation. 1997 Transplant. Proc. pmid:9365709
Paterson DL et al. Could a herpesvirus mimic tacrolimus-induced leukoencephalopathy? 1997 Ann. Neurol. pmid:9266742
Yoshimoto T et al. [Leukoencephalopathy probably caused by tacrolimus hydrate after stem cell transplantation in a girl with MDS 7 monosomy]. 1997 Rinsho Ketsueki pmid:9267167
Singh N et al. Invasive fungal infections in liver transplant recipients receiving tacrolimus as the primary immunosuppressive agent. 1997 Clin. Infect. Dis. pmid:9114144
Woodle ES et al. Reversal of accelerated renal allograft rejection with FK 506. 1997 Clin Transplant pmid:9267710
Eum SY et al. Inhibition by the immunosuppressive agent FK-506 of antigen-induced airways eosinophilia and bronchial hyperreactivity in mice. 1997 Br. J. Pharmacol. pmid:9117088
Ahsan N et al. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation. 1997 Clin Transplant pmid:9267713
Jacobson PA et al. Stability of tacrolimus in an extemporaneously compounded oral liquid. 1997 Am J Health Syst Pharm pmid:9117806
Singh N et al. Bloodstream infections in liver transplant recipients receiving tacrolimus. 1997 Clin Transplant pmid:9267715
Boucek MM et al. The Registry of the International Society of Heart and Lung Transplantation: first official pediatric report--1997. 1997 J. Heart Lung Transplant. pmid:9436131
Guo Z et al. In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function. 1997 Transplantation pmid:9075844
Gruessner RW Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. 1997 Clin Transplant pmid:9267719
Ciancio G et al. Use of intravenous FK506 to treat acute rejection in simultaneous pancreas-kidney transplant recipients on maintenance oral FK506. 1997 Transplantation pmid:9075856
Sherrington PD et al. TLiSA1 (PTA1) activation antigen implicated in T cell differentiation and platelet activation is a member of the immunoglobulin superfamily exhibiting distinctive regulation of expression. 1997 J. Biol. Chem. pmid:9268302
Mirza DF et al. Reduced acute rejection after liver transplantation with Neoral-based triple immunosuppression. 1997 Lancet pmid:9078209
Danovitch GM Cyclosporin or tacrolimus: which agent to choose? 1997 Nephrol. Dial. Transplant. pmid:9269630
Yoshikawa H et al. FK506 prevents induction of rat experimental autoimmune myasthenia gravis. 1997 J. Autoimmun. pmid:9080295
Filler G et al. Pharmacokinetics of tacrolimus (FK 506) in children and adolescents with renal transplants. 1997 Nephrol. Dial. Transplant. pmid:9269646
Yokoyama I et al. Fas antigen expression of hepatocytes and its modification by immunosuppressants. 1997 Dig. Dis. Sci. pmid:9440622
Sperr WR et al. Inhibition of allergen-induced histamine release from human basophils by cyclosporine A and FK-506. 1997 Int. Arch. Allergy Immunol. pmid:9303333
Azuma H et al. Atypical Epstein-Barr virus infection during and after intermittent FK506 therapy. 1997 Acta Paediatr Jpn pmid:9141259
Izuishi K et al. Effects of an immunosuppressive agent, tacrolimus (FK-506), on the activities of cytochrome P-450-linked monooxygenase systems in rat liver microsomes. 1997 Int. J. Biochem. Cell Biol. pmid:9304807
Tsuchida Y et al. Vascularized bone marrow allotransplantation in rats prolongs a simultaneous skin allograft. 1997 Transplant. Proc. pmid:9142252
Costa A et al. Small bowel myoelectrical activity after transplantation in pigs: motility versus ACR score. 1997 Transplant. Proc. pmid:9142281
Homey B et al. A local lymph node assay to analyse immunosuppressive effects of topically applied drugs. 1997 Eur. J. Pharmacol. pmid:9163567
Klupp J et al. Mycophenolate mofetil added to immunosuppression after liver transplantation--first results. 1997 Transpl. Int. pmid:9163864
McKee M et al. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients. 1997 J. Pediatr. Surg. pmid:9165452
Uno T et al. The pharmacokinetics of water-in-oil-in-water-type multiple emulsion of a new tacrolimus formulation. 1997 Lipids pmid:9168461
Jiang H et al. Distinct tissue and cellular distribution of two major isoforms of calcineurin. 1997 Mol. Immunol. pmid:9393969
Mignat C Clinically significant drug interactions with new immunosuppressive agents. 1997 Drug Saf pmid:9113494
Schweda F et al. Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome. 1997 Nephrol. Dial. Transplant. pmid:9394341
Sabatini DM et al. Neural roles of immunophilins and their ligands. 1997 Mol. Neurobiol. pmid:9396011
Su Y et al. Thyroid hormone induces apoptosis in primary cell cultures of tadpole intestine: cell type specificity and effects of extracellular matrix. 1997 J. Cell Biol. pmid:9396758
Bielefeldt K et al. Tacrolimus (FK506) modulates calcium release and contractility of intestinal smooth muscle. 1997 Cell Calcium pmid:9502200
Yamaguchi Y et al. Enhanced expression of cytokine-induced neutrophil chemoattractant in rat hepatic allografts during acute rejection. 1997 Hepatology pmid:9397996
Gruessner AC and Sutherland DE Pancreas transplants for United States (US) and non-US cases as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). 1997 Clin Transpl pmid:9919390
Odorico JS et al. Advances in pancreas transplantation: the University of Wisconsin experience. 1997 Clin Transpl pmid:9919400
Katznelson S et al. Clinical aspects of sensitization. 1997 Clin Transpl pmid:9919412
Pirenne J et al. Donor-specific unmodified bone marrow transfusion does not facilitate intestinal engraftment after bowel transplantation in a porcine model. 1997 Surgery pmid:9001555
Felldin M et al. Rescue therapy with tacrolimus (FK 506) in renal transplant recipients--a Scandinavian multicenter analysis. 1997 Transpl. Int. pmid:9002146
Becker G et al. Rescue therapy with tacrolimus in simultaneous pancreas/kidney transplantation. 1997 Transpl. Int. pmid:9002152
Odom A et al. The immunosuppressant FK506 and its nonimmunosuppressive analog L-685,818 are toxic to Cryptococcus neoformans by inhibition of a common target protein. 1997 Antimicrob. Agents Chemother. pmid:8980772
High KP and Washburn RG Invasive aspergillosis in mice immunosuppressed with cyclosporin A, tacrolimus (FK506), or sirolimus (rapamycin). 1997 J. Infect. Dis. pmid:8985226
Testa G and Klintmalm GB Cyclosporine and tacrolimus: the mainstay of immunosuppressive therapy for solid organ transplantation. 1997 Clin Liver Dis pmid:15562576
Noguchi N et al. Cyclic ADP-ribose binds to FK506-binding protein 12.6 to release Ca2+ from islet microsomes. 1997 J. Biol. Chem. pmid:9013543
Ishizuka T et al. Rapamycin potentiates dexamethasone-induced apoptosis and inhibits JNK activity in lymphoblastoid cells. 1997 Biochem. Biophys. Res. Commun. pmid:9016789